Market Cap

Qiagen N.V. Market Capitalization:

$9.80 Billion

USD as of Jan. 1, 2026

business Qiagen N.V. Company Profile

Qiagen N.V. Main Stock Listings

Market Capitalization History of Qiagen N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Qiagen N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $9.80 B -3.80%
Jan. 1, 2025 $10.19 B 1.92%
Jan. 1, 2024 $9.99 B -12.20%
Jan. 1, 2023 $11.38 B 0.26%
Jan. 1, 2022 $11.35 B -8.61%
Jan. 1, 2021 $12.42 B 60.30%
Jan. 1, 2020 $7.75 B -8.78%
Jan. 1, 2019 $8.49 B 10.57%
Jan. 1, 2018 $7.68 B 15.56%
Jan. 1, 2017 $6.65 B 22.76%
Jan. 1, 2016 $5.42 B -0.96%
Jan. 1, 2015 $5.47 B 3.66%
Jan. 1, 2014 $5.27 B 5.43%
Jan. 1, 2013 $5.00 B 29.67%
Jan. 1, 2012 $3.86 B -12.30%
Jan. 1, 2011 $4.40 B -15.21%
Jan. 1, 2010 $5.19 B 26.88%
Jan. 1, 2009 $4.09 B -15.93%
Jan. 1, 2008 $4.86 B 18.12%
Jan. 1, 2007 $4.12 B 45.86%
Jan. 1, 2006 $2.82 B 10.04%
Jan. 1, 2005 $2.57 B -17.42%
Jan. 1, 2004 $3.11 B 129.81%
Jan. 1, 2003 $1.35 B -70.17%
Jan. 1, 2002 $4.53 B -43.04%
Jan. 1, 2001 $7.96 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Qiagen N.V. Categories

Netherlands languages Healthcare languages Diagnostics & Research
Netherlands Healthcare Netherlands Diagnostics & Research

Stocks & Indices

Qiagen N.V. has the following listings and related stock indices.


Stock: NYSE: QGEN

Stock: XETR: QIA

Stock: FSX: QIA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.